HomeCompareBAX vs WBA

BAX vs WBA: Dividend Comparison 2026

BAX yields 2.28% · WBA yields 2.09%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 WBA wins by $322.00 in total portfolio value
10 years
BAX
BAX
● Live price
2.28%
Share price
$15.80
Annual div
$0.36
5Y div CAGR
-27%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.6K
Annual income
$10.26
Full BAX calculator →
WBA
WBA
● Live price
2.09%
Share price
$11.98
Annual div
$0.25
5Y div CAGR
-18.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.0K
Annual income
$30.14
Full WBA calculator →

Portfolio growth — BAX vs WBA

📍 WBA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBAXWBA
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BAX + WBA cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BAX pays
WBA pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BAX
Annual income on $10K today (after 15% tax)
$193.67/yr
After 10yr DRIP, annual income (after tax)
$8.72/yr
WBA
Annual income on $10K today (after 15% tax)
$177.38/yr
After 10yr DRIP, annual income (after tax)
$25.62/yr
At 15% tax rate, WBA beats the other by $16.90/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BAX + WBA for your $10,000?

BAX: 50%WBA: 50%
100% WBA50/50100% BAX
Portfolio after 10yr
$20.8K
Annual income
$20.20/yr
Blended yield
0.10%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BAX right now

BAX
Analyst Ratings
15
Buy
20
Hold
1
Sell
Consensus: Hold
Price Target
$19.75
+25.0% upside vs current
Range: $15.00 — $25.00
Altman Z
2.1
Piotroski
5/9
WBA
Analyst Ratings
5
Buy
17
Hold
9
Sell
Consensus: Hold
Price Target
$23.57
+96.7% upside vs current
Range: $9.00 — $57.00
Altman Z
2.3
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BAX buys
0
WBA buys
0
No recent congressional trades found for BAX or WBA in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBAXWBA
Forward yield2.28%2.09%
Annual dividend / share$0.36$0.25
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-27%-18.1%
Portfolio after 10y$20.6K$21.0K
Annual income after 10y$10.26$30.14
Total dividends collected$602.00$841.00
Payment frequencyquarterlyquarterly
SectorHealthcareConsumer Staples
Analyst consensusHoldHold
Analyst price target$19.75$23.57

Year-by-year: BAX vs WBA ($10,000, DRIP)

YearBAX PortfolioBAX Income/yrWBA PortfolioWBA Income/yrGap
1← crossover$10,866$166.33$10,871$170.91$5.00WBA
2$11,750$123.31$11,774$142.21$24.00WBA
3$12,664$90.97$12,716$117.89$52.00WBA
4$13,617$66.89$13,704$97.46$87.00WBA
5$14,619$49.07$14,743$80.39$124.00WBA
6$15,679$35.94$15,842$66.20$163.00WBA
7$16,802$26.30$17,005$54.45$203.00WBA
8$17,998$19.23$18,240$44.73$242.00WBA
9$19,272$14.05$19,554$36.73$282.00WBA
10$20,631$10.26$20,953$30.14$322.00WBA

BAX vs WBA: Complete Analysis 2026

BAXHealthcare

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Full BAX Calculator →

WBAConsumer Staples

Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores. It also provides central specialty pharmacy services and mail services. As of August 31, 2021, this segment operated 8,965 retail stores under the Walgreens and Duane Reade brands in the United States; and five specialty pharmacies. The International segment sells prescription drugs; and health and wellness, beauty, personal care, and other consumer products through its pharmacy-led health and beauty retail stores and optical practices, as well as through boots.com and an integrated mobile application. It also engages in pharmaceutical wholesaling and distribution business in Germany. As of August 31, 2021, this segment operated 4,031 retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile; and 548 optical practices, including 160 on a franchise basis. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.

Full WBA Calculator →
📬

Get this BAX vs WBA comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BAX vs SCHDBAX vs JEPIBAX vs OBAX vs KOBAX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.